Viewing Study NCT01510756


Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2026-05-19 @ 5:56 AM
Study NCT ID: NCT01510756
Status: TERMINATED
Last Update Posted: 2016-01-21
First Post: 2012-01-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Sponsor: Thomas Kipps
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
Keywords: